Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation [Phase 4]
Phase 4 clinical trial evaluating an oral and intravenous diltiazem protocol for emergency department management of atrial fibrillation and …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Acute Atrial Fibrillation and Flutter Treated Electively [NA]
Tampere University is conducting a clinical trial on elective treatment for acute atrial fibrillation and atrial flutter, and the study is c…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Stanford Cardiac Invasive Electrophysiology Novel Computer Experience
A Stanford-led clinical trial evaluating a novel computer-assisted approach in invasive electrophysiology for atrial arrhythmias has complet…
-
FDA approval · 2024-11-19FDA Approved: DIGOXIN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for Digoxin, granting regulatory approval for an update to an already …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Cavo-Tricuspid Isthmus Block Durability After Pulsed Electric Field Ablation [NA]
This clinical trial update assesses the durability of cavo-tricuspid isthmus block after pulsed electric field ablation in patients with atr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery
This clinical trial aims to detect perioperative atrial fibrillation after noncardiac surgery and is currently recruiting.
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
FDA approval · 2024-10-17FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone Hydrochloride filed by Strides Pharma Science Limited, adding a approved generic…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation [NA]
Clinical trial NCT04678258 is currently recruiting to compare zero-fluoroscopy voltage-guided ablation with linear CTI ablation for typical …
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant
A clinical trial update evaluating long-term risk of arrhythmias, including atrial fibrillation and atrial flutter, and other cardiovascular…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Cardiovascular Registry of Atrial Fibrillation
A completed cardiovascular registry trial update focusing on atrial fibrillation and atrial flutter is reported.
-
FDA approval · 2024-09-12FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for diltiazem hydrochloride by Mylan Pharmaceuticals Inc. under ANDA074910, indicating regulatory ap…
-
FDA approval · 2024-09-11FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals)
FDA approved the original application for Amiodarone hydrochloride (Slate Run Pharmaceuticals) as a generic antiarrhythmic agent.
-
FDA approval · 2024-09-09FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride (Hospira, Inc.), confirming it as an approved generic drug under an ANDA…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
A multicenter registry study assessing multimodal cardiac imaging in patients with atrial fibrillation, including AI-assisted echocardiograp…
-
FDA approval · 2024-08-21FDA Approved: DIGOXIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Digoxin submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: MCG for Localization of Tachyarrhythmia's Origin [NA]
A clinical trial update from Qilu Hospital of Shandong University describes using magnetocardiography to localize the origin of tachyarrhyth…
-
CLINICAL_TRIALS other · 2024-08-14Clinical Trial Update: Analysis of the Efficacy and Stability of a Wearable ECG Monitor [NA]
ClinicalTrials.gov entry describing a study to analyze the efficacy and stability of a wearable ECG monitor; the trial status is not yet rec…
-
FDA label_change · 2024-08-13FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) from Actavis Pharma, Inc. to update labeling for this long-a…
-
FDA approval · 2024-07-16FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection [NA]
HeartBeam's AIMIGo 12L ECG Synthesis Software completed its pivotal trial for detecting cardiac arrhythmias, including atrial fibrillation, …
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology [NA]
Columbia University-sponsored clinical trial evaluated using iPhone technology to help evaluate atrial fibrillation rhythm and atrial flutte…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring
This clinical trial update investigates triggers and risk factors associated with the recurrence of atrial arrhythmias during long-term moni…
-
FDA approval · 2024-06-20FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Lanoxin (digoxin) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation [NA]
A clinical trial comparing Vein of Marshall ethanol infusion ablation using an over-the-wire balloon with microcatheter ablation in patients…